Tomaž Goslar

Dr. Tomaž Goslar

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2017 in New England Journal of Medicine
Verified
Journal Article
Closed access
HTHolger Thiele
Holger Thiele
IAIbrahim Akin
Ibrahim Akin
MSMarcus Sandri
Marcus Sandri
GFGeorg Fuernau
Georg Fuernau
SWSuzanne de Waha
Suzanne de Waha
UZUwe Zeymer
Uwe Zeymer
In patients who have acute myocardial infarction with cardiogenic shock, early revascularization of the culprit artery by means of percutaneous coronary intervention (PCI) improves outcomes. However, the majority of patients with cardiogenic shock have multivessel disease, and whether PCI should be performed immediately for stenoses in nonculprit arteries is controversial.

1 November 2018 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
HTHolger Thiele
Holger Thiele
IAIbrahim Akin
Ibrahim Akin
MSMarcus Sandri
Marcus Sandri
SWSuzanne de Waha-Thiele
Suzanne de Waha-Thiele
RMRoza Meyer-Saraei
Roza Meyer-Saraei
SDSteffen Desch
Steffen Desch
Among patients with acute myocardial infarction, cardiogenic shock, and multivessel coronary artery disease, the risk of a composite of death from any cause or severe renal failure leading to renal-replacement therapy at 30 days was found to be lower with percutaneous coronary intervention (PCI) of the culprit lesion only than with immediate multivessel PCI. We evaluated clinical outcomes at 1 year. We randomly assigned 706 patients to either culprit-lesion-only PCI or immediate multivessel PCI. The results for the primary end point of death or renal-replacement therapy at 30 days have been reported previously. Prespecified secondary end points at 1 year included death from any cause, recurrent myocardial infarction, repeat revascularization, rehospitalization for congestive heart failure, the composite of death or recurrent infarction, and the composite of death, recurrent infarction, or rehospitalization for heart failure. As reported previously, at 30 days, the primary end point had occurred in 45.9% of the patients in the culprit-lesion-only PCI group and in 55.4% in the multivessel PCI group (P=0.01). At 1 year, death had occurred in 172 of 344 patients (50.0%) in the culprit-lesion-only PCI group and in 194 of 341 patients (56.9%) in the multivessel PCI group (relative risk, 0.88; 95% confidence interval [CI], 0.76 to 1.01). The rate of recurrent infarction was 1.7% with culprit-lesion-only PCI and 2.1% with multivessel PCI (relative risk, 0.85; 95% CI, 0.29 to 2.50), and the rate of a composite of death or recurrent infarction was 50.9% and 58.4%, respectively (relative risk, 0.87; 95% CI, 0.76 to 1.00). Repeat revascularization occurred more frequently with culprit-lesion-only PCI than with multivessel PCI (in 32.3% of the patients vs. 9.4%; relative risk, 3.44; 95% CI, 2.39 to 4.95), as did rehospitalization for heart failure (5.2% vs. 1.2%; relative risk, 4.46; 95% CI, 1.53 to 13.04). Among patients with acute myocardial infarction and cardiogenic shock, the risk of death or renal-replacement therapy at 30 days was lower with culprit-lesion-only PCI than with immediate multivessel PCI, and mortality did not differ significantly between the two groups at 1 year of follow-up. (Funded by the European Union Seventh Framework Program and others; CULPRIT-SHOCK ClinicalTrials.gov number, NCT01927549.)

1 July 2012 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
DKDragan Kovačić
Dragan Kovačić
NGNina Glavnik
Nina Glavnik
MMMatej Marinšek
Matej Marinšek
PZPetra Zagožen
Petra Zagožen
KRKsenija Rovan
Ksenija Rovan
MPMatej Podbregar
Matej Podbregar

1 June 2020 in Current Opinion in Critical Care
Verified
Journal Article
Closed access
RKRajat Kalra
Rajat Kalra
MKMarinos Kosmopoulos
Marinos Kosmopoulos
TGTomaž Goslar
Tomaž Goslar
GRGanesh Raveendran
Ganesh Raveendran
JBJason A. Bartos
Jason A. Bartos
DYDemetris Yannopoulos
Demetris Yannopoulos
Purpose of review: Extracorporeal cardiopulmonary resuscitation (ECPR) is a contemporary resuscitation approach that employs veno-arterial extracorporeal membrane oxygenation (VA-ECMO). This approach is increasingly used worldwide to mitigate the widespread hemodynamic and multiorgan dysfunction that accompanies cardiac arrest. Recent findings: In this review, the physiology of VA-ECMO and ECPR, the role of ECPR in contemporary resuscitation care, the complications associated with ECPR and VA-ECMO usage, and intensive care considerations for this population are discussed. Summary: ECPR offers a promising mechanism to mitigate multiorgan injury and allow time for the institution of supportive interventions required to effectively treat cardiac arrest. More prospective data in the context of extensive prehospital and hospital collaboration is needed to promote its successful use.

1 March 2021 in Resuscitation
Verified
Journal Article
Closed access
PRPeter Radsel
Peter Radsel
TGTomaž Goslar
Tomaž Goslar
MBMatjaz Bunc
Matjaz Bunc
JKJus Ksela
Jus Ksela
VGVojka Gorjup
Vojka Gorjup
MNMarko Noc
Marko Noc

24 November 2010 in Cardiovascular Ultrasound
Verified
Journal Article
Open access
PDF file
TGTomaž Goslar
Tomaž Goslar
MPMatej Podbregar
Matej Podbregar
Pulmonary embolism is a common cardiovascular emergency, but it is still often misdiagnosed due to its unspecific clinical symptoms. Elevated troponin concentrations are associated with greater morbidity and mortality in patients with pulmonary embolism. Right ventricular ischemia due to increased right ventricular afterload is believed to be underlying mechanism of elevated troponin values in acute pulmonary embolism, but a paradoxical coronary artery embolism through opened intra-artrial communication is another possible explanation as shown in our case report.